Mereo BioPharma Group plc Confidential and Anonymous Financial Concern Hotline

The SEC, in its final ruling regarding standards relating to Audit Committees, requires that Mereo BioPharma Group plc provide a facility for the receipt, retention and treatment of complaints received regarding accounting, internal accounting controls or auditing matters.

Please feel free to contribute any comments through this interface regarding such accounting matters. Your message is encrypted and will be delivered directly to the Audit Committee.

Understanding and acting upon any issues that exist regarding financial, accounting and/or audit matters is an essential component to Mereo BioPharma Group plc ability to take action and ensure the highest levels of financial fidelity.

You may leave a message using the Secure Web Form below


Click here to view frequently asked questions

Secure Web Form

Click here to file your case using a secure and encrypted web form.

When you send a message, you will receive back a 14 to 16-digit code that can be used to access the status of your message. The Audit Committee may also use this to ask you, with complete confidentiality, for additional information regarding this issue.

To anonymously follow up on your message, please click here.

Thank you. Integrity is everyone's responsibility at Mereo BioPharma Group plc.